- Home
- SRFM vs IMRX Comparison
SRFM vs IMRX Comparison
Compare SRFM & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRFM
- IMRX
- Stock Information
- Founded
- SRFM 2011
- IMRX 2008
- Country
- SRFM United States
- IMRX United States
- Employees
- SRFM N/A
- IMRX N/A
- Industry
- SRFM Transportation Services
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- SRFM Consumer Discretionary
- IMRX Health Care
- Exchange
- SRFM Nasdaq
- IMRX Nasdaq
- Market Cap
- SRFM 58.2M
- IMRX 68.4M
- IPO Year
- SRFM 2023
- IMRX 2021
- Fundamental
- Price
- SRFM $1.95
- IMRX $2.60
- Analyst Decision
- SRFM Strong Buy
- IMRX Strong Buy
- Analyst Count
- SRFM 3
- IMRX 4
- Target Price
- SRFM $6.42
- IMRX $13.25
- AVG Volume (30 Days)
- SRFM 778.7K
- IMRX 2.4M
- Earning Date
- SRFM 08-13-2025
- IMRX 08-05-2025
- Dividend Yield
- SRFM N/A
- IMRX N/A
- EPS Growth
- SRFM N/A
- IMRX N/A
- EPS
- SRFM N/A
- IMRX N/A
- Revenue
- SRFM $112,307,000.00
- IMRX N/A
- Revenue This Year
- SRFM N/A
- IMRX N/A
- Revenue Next Year
- SRFM $62.23
- IMRX N/A
- P/E Ratio
- SRFM N/A
- IMRX N/A
- Revenue Growth
- SRFM 31.17
- IMRX N/A
- 52 Week Low
- SRFM $0.90
- IMRX $1.00
- 52 Week High
- SRFM $6.72
- IMRX $3.83
- Technical
- Relative Strength Index (RSI)
- SRFM 39.50
- IMRX 70.10
- Support Level
- SRFM $1.91
- IMRX $1.66
- Resistance Level
- SRFM $2.48
- IMRX $2.24
- Average True Range (ATR)
- SRFM 0.24
- IMRX 0.32
- MACD
- SRFM -0.04
- IMRX 0.07
- Stochastic Oscillator
- SRFM 13.59
- IMRX 89.51
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.